Assessment of prognostic and predictive value of FGFR alterations (FGFRa) in a real-world cohort of patients (pts) with high-risk pT1 non-muscle-invasive bladder cancer (NMIBC)

Breyer J, Monga M, Mayr R, Otto W, Burger M, Eckstein M, Stöhr R, Erben P, Bolenz C, Eidt S, Sundaram R, Baig M, Galluzzi A, Wirtz R, Hartmann A, Santiago-Walker A (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Annals of Oncology Elsevier

Publisher: ELSEVIER

City/Town: AMSTERDAM

Pages Range: S587-S588

Conference Proceedings Title: ANNALS OF ONCOLOGY

DOI: 10.1016/j.annonc.2020.08.830

Authors with CRIS profile

Markus Eckstein Institute of Pathology Robert Stöhr Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Arndt Hartmann Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

Involved external institutions

Universität Regensburg DE Germany (DE) Janssen Global Services, LLC US United States (USA) (US) St. Elisabeth-Krankenhaus Köln-Hohenlind DE Germany (DE) Universität Ulm DE Germany (DE) Ruprecht-Karls-Universität Heidelberg DE Germany (DE)

How to cite

APA:

Breyer, J., Monga, M., Mayr, R., Otto, W., Burger, M., Eckstein, M.,... Santiago-Walker, A. (2020). Assessment of prognostic and predictive value of FGFR alterations (FGFRa) in a real-world cohort of patients (pts) with high-risk pT1 non-muscle-invasive bladder cancer (NMIBC). In ANNALS OF ONCOLOGY (pp. S587-S588). AMSTERDAM: ELSEVIER.

MLA:

Breyer, J., et al. "Assessment of prognostic and predictive value of FGFR alterations (FGFRa) in a real-world cohort of patients (pts) with high-risk pT1 non-muscle-invasive bladder cancer (NMIBC)." Proceedings of the ESMO Virtual Congress AMSTERDAM: ELSEVIER, 2020. S587-S588.

BibTeX: Download